Drugs / LNG+EE2
LNG+EE2
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01480778 | Jul 2014 → Apr 2015 | — | Azidus Brasil | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LNG+EE2 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01480778 ↗ |
| Known as | EE2 | “ethinylestradiol (EE2), a potent synthetic estrogen” PMID 12906905 ↗ Aug 2003 |
| Known as | ethinylestradiol | “ethinylestradiol (EE2), a potent synthetic estrogen” PMID 12906905 ↗ Aug 2003 |
| Modality | Small molecule | “ethinylestradiol (EE2), a potent synthetic estrogen” PMID 12906905 ↗ Aug 2003 |